Trial intelligence / Profile preview

Thiamine for prevention of delirium after gastrointestinal surgery in ICU patients

IRCT20190224042815N1Phase 3Not yet recruiting

Sponsor
Tehran University of Medical Sciences
Start
May 2640
Modality
Small Molecules
Countries
1
01

Overview

Phase 3, randomised, double-blind trial in delirium comparing Thiamine with Placebo (2 arms). Primary endpoints: Prevention of delirium, Hospitalization time and 1 more. Planned start May 2640; status: not yet recruiting.

02

Drugs

thiamine
03

Conditions

delirium

Beyond the preview

Go deeper on IRCT20190224042815N1.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on IRCT20190224042815N1.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call